The cell and gene therapy market is experiencing an unprecedented surge, driven by groundbreaking advancements and increasing investments in healthcare innovation. Join us as we uncover Market Growth, Impactful Case Studies, Global Expansion, and Key Innovators in the cell and gene therapy landscape.
Cell and gene therapy involves modification of cells or tissues to address or cure diseases. These therapies help treat a variety of conditions like cancer, genetic disorders, and infectious diseases. Cell therapies utilize stem cells, while gene therapies focus on altering genes to fight disease.
According to BCC Research, the cell and gene therapy market size is anticipated to expand significantly. From $7.2 billion in 2023, it is projected to soar to $23.3 billion by the end of 2028. This remarkable growth is notably attributed to advancements in biotechnology, escalating investments in research and development, and the increasing prevalence of chronic diseases and genetic disorders.
Remarkably, this market is expected to achieve an unprecedented compound annual growth rate (CAGR) of 26.4% during the forecast period.